Dr. Leena Gandhi

Dr. Leena Gandhi

Thoracic Oncologist

Dr. Leena Gandhi most recently served as Director of Thoracic Medical Oncology at NYU Perlmutter Cancer Center. She has spent her career taking care of lung cancer patients and running clinical trials. Her research is focused on understanding how and why patients respond to therapy by evaluating certain markers–genetic changes, proteins, and other features–in blood or tumor tissue.

Dr. Gandhi’s is currently the lead of immuno-oncology medical development at Eli Lilly. She’s heading up a team tasked with overseeing the advancement of Lilly’s portfolio of immuno-oncology prospects.

Later Stage

Combining Immunotherapy Drugs in Lung Cancer Clinical Trials
Treatment

Is Immunotherapy Right for My Lung Cancer?
Treatment

When Should I Consider Clinical Trials?
Treatment

The Outlook for Immunotherapy Treatment
Later Stage

Clinical Trials for Late Stage Lung Cancer
Treatment

How to Determine If Targeted Therapy Is Right for You
Diagnosis

Diagnosing Lung Cancer and Determining Treatment
Close

SN GUIDES

The First 60

Begin the breast cancer journey with confidence.

SIGN UP NOW

Thank you!

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.